Fact CheckerSign in

NCT06159309Active, not recruiting

Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients

Source: ClinicalTrials.gov · Last updated 4 Jun 2025

Brief summary (registry, in English)

Post-Covid syndrome, also known as long Covid, is a clinical condition in which patients experience long term symptoms after Covid-19 infection. Treatment options for post-Covid are not effective. Therefore, there is an urgent need for a novel therapy. The first study results of HBOT in post-Covid patients are promising. Previous research from Israel has shown improvements in quality of life after HBOT. However, long term results are unknown. Therefore, this study aims to evaluate quality of life at one year after hyperbaric oxygen therapy in post-Covid patients with cognitive symptoms. It is hypothesized that quality of life at one year after HBOT is improved. Furthermore, this study aims to evaluate return to work after HBOT. To our knowledge this was not done before. An observational prospective cohort study will be conducted to answer the research questions. All post-Covid patients who are treated with hyperbaric oxygen therapy in participating centers, will be eligible for inclusion. Questionnaires and medical doctor consultations will be used in order to collect all data. There are no risks for participants, since only 7 questionnaires are not part of standard clinical care. The burden is approximately 40 minutes extra in total for participants, compared to standard clinical care.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
4 Dec 2023
Start date
6 Feb 2023
Primary completion date
30 Jun 2025
Lead sponsor
Rutger Lalieu
NCT number
NCT06159309

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 6 Feb 2023 to the primary completion date, 30 Jun 2025
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients who are not able to fill in questionnaires and informed consent.
  • Patients who can't read or do not understand the Dutch language

Who the study is looking for

  • Long COVID patients who are reffered for treatment with hyperbaric oxygen therapy
  • Patients are suffering from cognitive symptoms for \>3 months after Covid infection

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
DVK Amersfoort
Coordinator of this site? Confirm its status
AmersfoortNetherlandsUnknown status
DVK Geldrop
Coordinator of this site? Confirm its status
GeldropNetherlandsUnknown status
DVK Hogeveen
Coordinator of this site? Confirm its status
HoogeveenNetherlandsUnknown status
HGC Rijswijk
Coordinator of this site? Confirm its status
RijswijkNetherlandsUnknown status
DVK Rotterdam
Coordinator of this site? Confirm its status
RotterdamNetherlandsUnknown status
DVK Waalwijk
Coordinator of this site? Confirm its status
WaalwijkNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.